VIVIMED LABS
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Vivimed Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-4.91₹ -0.38
As on Jan 21, 2026, 4:01 PM IST
Vivimed Labs Price Performance
Today's LowToday's High
₹7.36₹7.36
₹7.36
52 Weeks' Low52 Weeks' High
₹7.36₹27.99
₹7.36
Open Price
₹7.36
Prev. Close
₹7.74
Volume
3,03,714
Over the last 5 years, the share price of Vivimed Labs has declined 15.27% CAGR. Over the past year, the corresponding return has been -72.24%.
Vivimed Labs’s current P/E of -2.50x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Vivimed Labs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Vivimed Labs | -18.31 | -69.26 | -72.24 | -72.24 | -72.24 | -8.16 | -15.27 |
| Sun Pharmaceutical Industries | -5.32 | -9.10 | -4.74 | -4.82 | -8.61 | 15.33 | 22.53 |
| Divi's Laboratories | -5.54 | -7.79 | -8.93 | -10.25 | 3.20 | 21.04 | 10.74 |
| Torrent Pharmaceuticals | -1.24 | 3.69 | 10.16 | 12.22 | 25.25 | 35.31 | 23.63 |
| Cipla | -4.53 | -9.45 | -17.69 | -7.18 | -4.05 | 8.83 | 10.99 |
| Lupin | -2.49 | 0.67 | 10.14 | 11.39 | 1.76 | 40.87 | 14.91 |
| Dr. Reddy's Laboratories | -2.61 | -10.00 | -10.40 | -8.26 | -10.32 | 10.02 | 2.72 |
| Zydus Lifesciences | -1.01 | -4.69 | -12.48 | -9.76 | -11.22 | 25.40 | 13.27 |
| Mankind Pharma | -6.58 | -4.17 | -14.32 | -20.79 | -18.22 | 13.76 | 8.04 |
| Alkem Laboratories | -2.78 | 0.84 | 2.09 | 13.37 | 9.48 | 23.04 | 13.00 |
| Aurobindo Pharma | -4.33 | -7.76 | 2.56 | -0.81 | -4.85 | 36.32 | 4.58 |
| Biocon | -3.71 | -8.53 | -0.19 | -7.48 | -6.48 | 13.69 | -3.75 |
| Abbott India | -0.76 | -1.13 | -8.49 | -18.70 | 0.17 | 8.23 | 13.82 |
| Glenmark Pharmaceuticals | -3.26 | -4.54 | 4.86 | -10.88 | 29.75 | 66.88 | 31.35 |
| Laurus Labs | -9.38 | -7.02 | 7.02 | 19.21 | 71.39 | 41.60 | 21.72 |
| GlaxoSmithKline Pharmaceuticals | -4.30 | -9.25 | -17.09 | -26.54 | 6.90 | 21.47 | 8.53 |
| Ipca Laboratories | -3.04 | 3.08 | 14.70 | 0.25 | -4.76 | 18.99 | 7.43 |
| Ajanta Pharma | 0.05 | 0.22 | 10.34 | -2.47 | -4.41 | 31.26 | 18.41 |
| Anthem Biosciences | -4.59 | -12.74 | -19.96 | -18.67 | -18.67 | -6.66 | -4.05 |
| J B Chemicals & Pharmaceuticals | -0.64 | 4.12 | 11.21 | 11.70 | 4.63 | 24.06 | 30.10 |
Over the last one year, Vivimed Labs has declined 72.24% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (3.20%), Torrent Pharmaceuticals (25.25%). From a 5 year perspective, Vivimed Labs has underperformed peers relative to Sun Pharmaceutical Industries (22.53%) and Divi's Laboratories (10.74%).
Vivimed Labs Financials
Vivimed Labs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 9.5 | 9.13 |
| 10 | 11.11 | 10.6 |
| 20 | 16.2 | 11.88 |
| 50 | 10.69 | 11.58 |
| 100 | 10.65 | 11.11 |
| 200 | 10.44 | 11.73 |
Vivimed Labs Share Holding Pattern
In the latest quarter, Vivimed Labs remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 1.64%, and public shareholding unchanged at 90.47% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Vivimed Labs Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 13, 2026, 11:03 PM IST | Vivimed Labs - Intimation |
| Jan 07, 2026, 10:00 PM IST | Vivimed Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jan 06, 2026, 6:09 AM IST | Vivimed Labs - Clarification On Price Movement |
| Jan 06, 2026, 12:30 AM IST | Vivimed Labs - Clarification sought from Vivimed Labs Ltd |
| Dec 11, 2025, 4:56 PM IST | Vivimed Labs - Revocation Of Suspension In Trading Of Equity Shares |
About Vivimed Labs
Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 103.60 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 78/A, Kolhar Industrial Area, Bidar Karnataka 585403
- Contact
Management
- Dr. Manohar Rao VaralwarChairman & Wholetime Director
- Mr. Santosh VaralwarManaging Director
- Mr. Sandeep VaralwarWhole Time Director
- Ms. Aparna BidarkarIndependent Director
- Ms. Subbarathnamma PalepuIndependent Director
- Mr. Jarugula Siva PrasadIndependent Director
FAQs on Vivimed Labs Share Price
What is the share price of Vivimed Labs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vivimed Labs is ₹7.36 as on Jan 21, 2026.
What kind of stock is Vivimed Labs?
The Vivimed Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Vivimed Labs?
The market cap of Vivimed Labs is ₹61.02 Cr as on Jan 21, 2026.
What are today's High and Low prices of Vivimed Labs?
Today’s highest and lowest price of Vivimed Labs are ₹7.36 and ₹7.36.
What are the 52 Week High and 52 Week Low of Vivimed Labs?
The 52-week high/low is the highest and lowest price at which Vivimed Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Vivimed Labs is ₹27.99 and 52-week low of Vivimed Labs is ₹7.36 as on Jan 21, 2026.
How has the Vivimed Labs performed historically in terms of returns?
The Vivimed Labs has shown returns of -4.91% over the past day, -69.26% for the past month, -72.24% over 3 months, -72.24% over 1 year, -8.16% across 3 years, and -15.27% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Vivimed Labs?
P/E ratio of and PB ratio of Vivimed Labs are -2.50 and -0.83 on Jan 21, 2026. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse